These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3021035)

  • 1. Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
    Graybill JR; Palou E; Ahrens J
    Am Rev Respir Dis; 1986 Oct; 134(4):768-70. PubMed ID: 3021035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection].
    Bérard H; Astoul P; Frenay C; Cuguillière A; Cho K; Boutin C
    Rev Mal Respir; 1999 Nov; 16(5):829-31. PubMed ID: 10612153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
    Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ
    J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage treatment of histoplasmosis with posaconazole.
    Restrepo A; Tobón A; Clark B; Graham DR; Corcoran G; Bradsher RW; Goldman M; Pankey G; Moore T; Negroni R; Graybill JR
    J Infect; 2007 Apr; 54(4):319-27. PubMed ID: 16824608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice.
    Kobayashi GS; Travis SJ; Medoff G
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2005-6. PubMed ID: 2830843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nikkomycin Z in the treatment of murine histoplasmosis.
    Graybill JR; Najvar LK; Bocanegra R; Hector RF; Luther MF
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2371-4. PubMed ID: 9736565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
    Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
    Graybill JR; Sun SH; Ahrens J
    J Med Vet Mycol; 1986 Apr; 24(2):113-9. PubMed ID: 3014105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cryptococcal meningitis in mice with fluconazole.
    Palou de Fernandez E; Patino MM; Graybill JR; Tarbit MH
    J Antimicrob Chemother; 1986 Aug; 18(2):261-70. PubMed ID: 3019986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    Troke PF; Andrews RJ; Marriott MS; Richardson K
    J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
    Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
    Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
    Polak A; Dixon DM
    Mykosen; 1987 Apr; 30(4):186-94. PubMed ID: 3035371
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of pulmonary mycoses].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Histoplasmosis: not only a tropical disease].
    Bregani ER; Van Tien T; Ceraldi T; Delfitto C; Figini G
    Recenti Prog Med; 2000; 91(7-8):396-401. PubMed ID: 10932927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of sordarins in murine histoplasmosis.
    Graybill JR; Najvar L; Fothergill A; Bocanegra R; de las Heras FG
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1716-8. PubMed ID: 10390228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis.
    Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1995 Mar; 39(3):778-80. PubMed ID: 7793893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis S; Medoff G
    Antimicrob Agents Chemother; 1986 Apr; 29(4):660-2. PubMed ID: 3010852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental chemotherapy of histoplasmosis in nude mice.
    Williams DM; Graybill JR; Drutz DJ
    Am Rev Respir Dis; 1979 Oct; 120(4):837-42. PubMed ID: 507510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of cryptococcosis and histoplasmosis by ketoconazole in athymic nude mice.
    Williams DM; Graybill JR; Drutz DJ; Levine HB
    J Infect Dis; 1980 Jan; 141(1):76-80. PubMed ID: 6988519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.